NCT06403501View on ClinicalTrials.gov

Efficacy and Safety of Clascoterone Cream 1% in Facial Acne Vulgaris

PHASE3RecruitingINTERVENTIONAL
Enrollment

692

Participants

Timeline

Start Date

May 20, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Acne Vulgaris
Interventions
DRUG

Clascoterone

Clascoterone Cream 1% (Winlevi) is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older.

DRUG

Vehicle cream

Vehicle cream manufactured to mimic look and feel of Clascoterone Cream 1% but without the active ingredient.

Trial Locations (1)

Unknown

RECRUITING

Huashan Hospital, Fudan University, Shanghai

All Listed Sponsors
lead

Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.

INDUSTRY